O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and Low MGMT-Encoded Protein Expression as Prognostic Markers in Glioblastoma Patients Treated with Biodegradable Carmustine Wafer Implants after Initial Surgery Followed by Radiotherapy with Concomitant and Adjuvant Temozolomide

Js Guillamo 1 G Levallet 1 A Dugué 1 A Vital 1 Md Diebold 1 P Menei 1 P Colin 1 P Peruzzy 1 E Emery 1 M Bernaudin 2 F Chapon 1 E Lechapt-Zalcman 2
2 CERVOxy - Hypoxie, physiopathologies cérébrovasculaire et tumorale
ISTCT - Imagerie et Stratégies Thérapeutiques des pathologies Cérébrales et Tumorales
Type de document :
Communication dans un congrès
Liste complète des métadonnées

https://hal-normandie-univ.archives-ouvertes.fr/hal-02265457
Contributeur : Carole Brunaud <>
Soumis le : vendredi 9 août 2019 - 17:04:13
Dernière modification le : vendredi 4 octobre 2019 - 09:15:28

Identifiants

  • HAL Id : hal-02265457, version 1

Citation

Js Guillamo, G Levallet, A Dugué, A Vital, Md Diebold, et al.. O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and Low MGMT-Encoded Protein Expression as Prognostic Markers in Glioblastoma Patients Treated with Biodegradable Carmustine Wafer Implants after Initial Surgery Followed by Radiotherapy with Concomitant and Adjuvant Temozolomide. 64th Annual Meeting of the American-Academy-of-Neurology (AAN), Apr 2012, New Orleans, United States. pp.P06.004. ⟨hal-02265457⟩

Partager

Métriques

Consultations de la notice

18